Lumbar disc herniation
Conditions
Interventions
trial group:Zhuangyao Tongluo decoction granules + Celecoxib capsule simulator
Control group:Zhuangyao Tongluo Decoction simulator + Celecoxib capsule
Sponsors
China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1)Comply with the diagnostic criteria of lumbar disc herniation; 2) Aged between 18 and 75 years old; 3)If you have received other conservative treatment, you need more than 7 days of wash-out period; 4) Volunteer to participate, sign the informed consent form, and be willing to accept the test; 5)leg VAS pain score = 4 and < 7. Those who meet the above five options are eligible for this clinical study.
Exclusion criteria
Exclusion criteria: 1 ) Patients with spinal infections, tumors, tuberculosis, traumatic fractures, ankylosing spondylitis, etc. 2 ) Patients with severe pain, cauda equina nerve symptoms or lower limb muscle strength decrease who met the surgical indications. 3 ) Patients with previous lumbar surgery ; 4 ) Pregnancy and lactation women. 5 ) Patients with mental diseases or other reasons that do not cooperate. 6 ) Patients with severe cardiovascular, renal, liver, gastrointestinal ulcers, hematopoietic system diseases. 7 ) Patients with allergic constitution or known allergy to drugs and their components ( including sulfonamides ) used in this experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS scores of leg pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| SF-12;ODI scores;JOA scores;VAS scores of lumbar pain; | — |
Countries
China
Contacts
Public ContactYang Kexin
Outcome results
None listed